Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Towards Predicting the Cytochrome P450 Modulation: From QSAR to Proteochemometric Modeling.

Shoombuatong W, Prathipati P, Prachayasittikul V, Schaduangrat N, Malik AA, Pratiwi R, Wanwimolruk S, Wikberg JES, Gleeson MP, Spjuth O, Nantasenamat C.

Curr Drug Metab. 2017 Jul 21;18(6):540-555. doi: 10.2174/1389200218666170320121932. Review.

PMID:
28322159
2.

Food safety in Thailand 4: comparison of pesticide residues found in three commonly consumed vegetables purchased from local markets and supermarkets in Thailand.

Wanwimolruk S, Phopin K, Boonpangrak S, Prachayasittikul V.

PeerJ. 2016 Sep 1;4:e2432. doi: 10.7717/peerj.2432. eCollection 2016.

3.

Food safety in Thailand. 3: Pesticide residues detected in mangosteen (Garcinia mangostana L.), queen of fruits.

Phopin K, Wanwimolruk S, Prachayasittikul V.

J Sci Food Agric. 2017 Feb;97(3):832-840. doi: 10.1002/jsfa.7804. Epub 2016 Jun 27.

PMID:
27185538
4.

Food safety in Thailand 2: Pesticide residues found in Chinese kale (Brassica oleracea), a commonly consumed vegetable in Asian countries.

Wanwimolruk S, Kanchanamayoon O, Phopin K, Prachayasittikul V.

Sci Total Environ. 2015 Nov 1;532:447-55. doi: 10.1016/j.scitotenv.2015.04.114. Epub 2015 Jun 18.

PMID:
26093223
5.

Food safety in Thailand 1: it is safe to eat watermelon and durian in Thailand.

Wanwimolruk S, Kanchanamayoon O, Boonpangrak S, Prachayasittikul V.

Environ Health Prev Med. 2015 May;20(3):204-15. doi: 10.1007/s12199-015-0452-8. Epub 2015 Feb 20.

6.

Cytochrome P450 enzyme mediated herbal drug interactions (Part 2).

Wanwimolruk S, Phopin K, Prachayasittikul V.

EXCLI J. 2014 Aug 20;13:869-96. eCollection 2014. Review.

7.

Cytochrome P450 enzyme mediated herbal drug interactions (Part 1).

Wanwimolruk S, Prachayasittikul V.

EXCLI J. 2014 Apr 2;13:347-91. eCollection 2014. Review.

8.

Effect of cranberry dietary supplements with different brands on human CYP3A4 enzyme.

Wanwimolruk S, Prachayasittikul S, Prachayasittikul V, Bernichi B.

EXCLI J. 2012 Mar 28;11:108-15. eCollection 2012.

9.

Variable inhibitory effect of herbal supplements of different brands on human P450 CYP1A2.

Wanwimolruk S, Prachayasittikul V.

EXCLI J. 2012 Feb 2;11:7-19. eCollection 2012.

10.

Relevance of drug metabolizing enzyme activity modulation by tea polyphenols in the inhibition of esophageal tumorigenesis.

Maliakal P, Sankpal UT, Basha R, Maliakal C, Ledford A, Wanwimolruk S.

Med Chem. 2011 Sep;7(5):480-7.

PMID:
21801144
11.

Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4.

Wanwimolruk S, Wong K, Wanwimolruk P.

Drug Metabol Drug Interact. 2009;24(1):17-35.

PMID:
19353999
12.

Characterization of CYP1A enzyme in Adélie penguin liver.

Wanwimolruk S, Wanwimolruk P.

Comp Biochem Physiol C Toxicol Pharmacol. 2006 Oct;144(2):148-54. Epub 2006 Jul 29.

PMID:
16949883
13.

Variations in content of active ingredients causing drug interactions in grapefruit juice products sold in California.

Wanwimolruk S, Marquez PV.

Drug Metabol Drug Interact. 2006;21(3-4):233-43.

PMID:
16841515
14.

Ontogeny of hepatic microsomal 3-hydroxylation of quinine in Adélie Penguins.

Numata M, Fawcett JP, Rosengren RJ, Wanwimolruk S.

Comp Biochem Physiol C Toxicol Pharmacol. 2004 May;138(1):53-8.

PMID:
15313446
15.

Effects of Chinese, Japanese and Western tea on hepatic P450 enzyme activities in rats.

Niwattisaiwong N, Luo XX, Coville PF, Wanwimolruk S.

Drug Metabol Drug Interact. 2004;20(1-2):43-56.

PMID:
15283302
16.

Quinine pharmacokinetic-pharmacodynamic relationships in uncomplicated falciparum malaria.

Pukrittayakamee S, Wanwimolruk S, Stepniewska K, Jantra A, Huyakorn S, Looareesuwan S, White NJ.

Antimicrob Agents Chemother. 2003 Nov;47(11):3458-63.

17.

Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria.

Pukrittayakamee S, Prakongpan S, Wanwimolruk S, Clemens R, Looareesuwan S, White NJ.

Antimicrob Agents Chemother. 2003 May;47(5):1509-13.

18.

Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?

Wanwimolruk S, Paine MF, Pusek SN, Watkins PB.

Br J Clin Pharmacol. 2002 Dec;54(6):643-51.

19.

Decreased hepatic drug metabolising enzyme activity in rats with nitrosamine-induced tumours.

Maliakal PP, Coville PF, Wanwimolruk S.

Drug Metabol Drug Interact. 2002;19(1):13-27.

PMID:
12222751
20.

Effects of cigarette smoking on quinine pharmacokinetics in malaria.

Pukrittayakamee S, Pitisuttithum P, Zhang H, Jantra A, Wanwimolruk S, White NJ.

Eur J Clin Pharmacol. 2002 Aug;58(5):315-9. Epub 2002 Jun 20.

PMID:
12185554
21.

Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.

Ho PC, Saville DJ, Wanwimolruk S.

J Pharm Pharm Sci. 2001 Sep-Dec;4(3):217-27.

22.

Effect of herbal teas on hepatic drug metabolizing enzymes in rats.

Maliakal PP, Wanwimolruk S.

J Pharm Pharmacol. 2001 Oct;53(10):1323-9.

PMID:
11697539
23.

Oral quinine pharmacokinetics and dietary salt intake.

Newton P, Simpson A, Wanwimolruk S, Maliakal P, Villegas L, Kuypers D, White NJ.

Eur J Clin Pharmacol. 2001 May;57(2):111-3.

PMID:
11417441
24.

Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats.

Maliakal PP, Coville PF, Wanwimolruk S.

J Pharm Pharmacol. 2001 Apr;53(4):569-77.

PMID:
11341376
25.

Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers.

Ho PC, Ghose K, Saville D, Wanwimolruk S.

Eur J Clin Pharmacol. 2000 Dec;56(9-10):693-8.

PMID:
11214778
26.

Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats.

Zhang H, Wong CW, Coville PF, Wanwimolruk S.

Drug Metabol Drug Interact. 2000;17(1-4):351-63.

PMID:
11201303
27.

Pharmacokinetics of quinine in obesity.

Viriyayudhakorn S, Thitiarchakul S, Nachaisit S, Ho PC, Wanwimolruk S.

Trans R Soc Trop Med Hyg. 2000 Jul-Aug;94(4):425-8.

PMID:
11127249
28.

Toxicological evaluation of New Zealand deer velvet powder. Part I: acute and subchronic oral toxicity studies in rats.

Zhang H, Wanwimolruk S, Coville PF, Schofield JC, Williams G, Haines SR, Suttie JM.

Food Chem Toxicol. 2000 Nov;38(11):985-90.

PMID:
11038235
29.

Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products.

Ho PC, Saville DJ, Coville PF, Wanwimolruk S.

Pharm Acta Helv. 2000 Apr;74(4):379-85.

PMID:
10812937
30.

In vitro hepatic metabolism of a CYP3A-mediated drug, quinine, in Adélie penguins.

Wanwimolruk S, Zhang H, Coville PF, Saville DJ, Davis LS.

Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1999 Nov;124(3):301-7.

PMID:
10661723
31.

Grapefruit juice has no effect on quinine pharmacokinetics.

Ho PC, Chalcroft SC, Coville PF, Wanwimolruk S.

Eur J Clin Pharmacol. 1999 Jul;55(5):393-8.

PMID:
10456490
32.

Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations.

Wanwimolruk S, Bhawan S, Coville PF, Chalcroft SC.

Eur J Clin Pharmacol. 1998 Jul;54(5):431-5.

PMID:
9754989
33.

Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine.

Zhang H, Coville PF, Walker RJ, Miners JO, Birkett DJ, Wanwimolruk S.

Br J Clin Pharmacol. 1997 Mar;43(3):245-52.

34.

Modeling of subcutaneous absorption kinetics of infusion solutions in the elderly using technetium.

Roberts MS, Lipschitz S, Campbell AJ, Wanwimolruk S, McQueen EG, McQueen M.

J Pharmacokinet Biopharm. 1997 Feb;25(1):1-21.

PMID:
9353691
35.
36.

Metabolism of quinine in man: identification of a major metabolite, and effects of smoking and rifampicin pretreatment.

Wanwimolruk S, Wong SM, Zhang H, Coville PF, Walker RJ.

J Pharm Pharmacol. 1995 Nov;47(11):957-63.

PMID:
8708992
37.

Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population.

Wanwimolruk S, Thou MR, Woods DJ.

Br J Clin Pharmacol. 1995 Aug;40(2):166-9.

38.

Evidence for the polymorphic oxidation of debrisoquine and proguanil in a New Zealand Maori population.

Wanwimolruk S, Pratt EL, Denton JR, Chalcroft SC, Barron PA, Broughton JR.

Pharmacogenetics. 1995 Aug;5(4):193-8.

PMID:
8528265
39.

Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.

Wanwimolruk S, Kang W, Coville PF, Viriyayudhakorn S, Thitiarchakul S.

Br J Clin Pharmacol. 1995 Jul;40(1):87-91.

40.

Cigarette smoking enhances the elimination of quinine.

Wanwimolruk S, Wong SM, Coville PF, Viriyayudhakorn S, Thitiarchakul S.

Br J Clin Pharmacol. 1993 Dec;36(6):610-4.

41.

Effects of capsaicin on the pharmacokinetics of antipyrine, theophylline and quinine in rats.

Wanwimolruk S, Nyika S, Kepple M, Ferry DG, Clark CR.

J Pharm Pharmacol. 1993 Jul;45(7):618-21.

PMID:
8105056
42.

A clinical trial of a slow-release formulation of acetylsalicylic acid in patients at risk for preeclampsia.

Shen J, Wanwimolruk S, Wilson PD, Seddon RJ, Roberts MS.

Br J Clin Pharmacol. 1993 Jun;35(6):664-7.

43.

The binding of the antimalarial arteether to human plasma proteins in-vitro.

Wanwimolruk S, Edwards G, Ward SA, Breckenridge AM.

J Pharm Pharmacol. 1992 Nov;44(11):940-2.

PMID:
1361544
44.
45.

Polymorphism of debrisoquine oxidation in New Zealand Caucasians.

Wanwimolruk S, Denton JR, Ferry DG, Beasley M, Broughton JR.

Eur J Clin Pharmacol. 1992;42(3):349-50. No abstract available.

PMID:
1577057
46.

Sensitive high-performance liquid chromatographic determination of famotidine in plasma. Application to pharmacokinetic study.

Wanwimolruk S, Zoest AR, Wanwimolruk SZ, Hung CT.

J Chromatogr. 1991 Dec 6;572(1-2):227-38.

PMID:
1818056
47.
48.

Pharmacokinetics of quinine in young and elderly subjects.

Wanwimolruk S, Chalcroft S, Coville PF, Campbell AJ.

Trans R Soc Trop Med Hyg. 1991 Nov-Dec;85(6):714-7.

PMID:
1801332
49.
50.

Supplemental Content

Loading ...
Support Center